Privia Health Group, Inc. - Common Stock (PRVA)

CUSIP: 74276R102

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
+3,803,526
Put/Call ratio
180%
SEC-reported price per share
$22.71
Number of holders
191
Value change
+$55,164,567
Number of buys
109
Open additional details 1 more signal available
Number of sells
96
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
127,964,499

Security key

74276R102

Report period

Q4 2022

Institutions

191

Top holders

10

Ownership snapshot

Top reported holders of PRVA - Privia Health Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Pamplona Capital Manageme...
Disclosed value leader
Pamplona Capital Manageme...
Comparable rows
0/15
Latest evidence
10 Nov 2022
3/4/5 13F Highest disclosed value: $2,301,083,280 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Pamplona Capital Management, LLC has the largest disclosed position value at $2.3B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Pamplona Capital Management, LLC's linked filing trail.
Disclosed position value Top 5
Pamplona Capital Management, LLC $2.3B
Brighton Health Group Holdings, LLC $144
GOLDMAN SACHS GROUP INC $954.1M
VANGUARD GROUP INC $164.33M
Bank of New York Mellon Corp $124.44M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Pamplona Capital Management, LLC
3/4/5
10%+ Owner
—
denominator unverified
$2,301,083,280
95,878,470 shares
— 28 Apr 2021
Brighton Health Group Holdings, LLC
3/4/5
10%+ Owner
—
denominator unverified
$144
6 shares
— 11 May 2021
GOLDMAN SACHS GROUP INC
13F
Company
13F
—
denominator unverified
$954,096,000
28,012,203 shares
— 30 Sep 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$164,331,000
4,824,724 shares
— 30 Sep 2022
Bank of New York Mellon Corp
13F
Company
13F
—
denominator unverified
$124,439,000
3,653,534 shares
— 30 Sep 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$111,846,000
3,283,793 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
191
Shares
80,892,195
Rows available
191
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
202
Q4 2022 holders
191
Holder diff
-11
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .